Share on LinkedInShare on LinkedIn

ARTICLE · 04 FEBRUARY 2021

Keeping It Cool - COVID-19 Vaccine Delivery

William Fry LLP
William Fry LLP
Contributor
William Fry LLP

William Fry LLP

William Fry advises leading Irish and international companies, covering both the public and private...

View firm profile
Explore more from William Fry LLP

The European Commission and AstraZeneca have recently become embroiled in a dispute about AstraZeneca's obligations to deliver its vaccine to the EU.

European UnionCoronavirus (COVID-19)
The European Commission and AstraZeneca have recently become embroiled in a dispute about AstraZeneca's obligations to deliver its vaccine to the EU. AstraZeneca notified the European Commission (Commission) that, due to production problems in its Dutch and Belgian plants, it would have to cut its supply to the EU by over 60%. This resulted in a public dispute between the parties whereby the Commission insisted that AstraZeneca has a contractual obligation to deliver the agreed volume of the vaccine and could not renege on those obligations. The Commission even went as far as publishing a redacted version of the contract to illustrate its point. However, AstraZeneca stated that it only had to provide its "best reasonable efforts" in respect of the timeline and volume of vaccine delivery. While this dispute is being played out in a public forum by two large players, it is likely given the scale of the vaccine rollout, that other disputes will arise between smaller

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from